Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Long-acting reversible contraception

Clinical guideline
Reference number: CG30
Published: 26 October 2005
Last updated: 02 July 2019

History

Surveillance consultation

Surveillance consultation
Comments form (MSWord 27 KB)

Published:

27 February 2017
Surveillance review proposal (PDF 744 KB)

Published:

27 February 2017

Stakeholder list updated

Stakeholder list (PDF 39 KB)

Published:

22 February 2017

Review documents

CG30 Long-acting reversible contraception: review consultation information
CG30 Long-acting reversible contraception: review consultation document (PDF 144 KB)

Published:

31 January 2011
Long-acting contraception - list of stakeholders (PDF 23 KB)

Published:

21 December 2004
Long-acting contraception - list of stakeholders (PDF 23 KB)

Published:

21 December 2004
CG30 Long-acting reversible contraception: review proposal consultation comments table (PDF 59 KB)

Published:

25 February 2011
CG30 Long-acting reversible contraception: review decision (PDF 68 KB)

Published:

25 February 2011
CG30 Long-acting reversible contraception: surveillance review proposal consultation information
CG30 Long-acting reversible contraception: surveillance review proposal consultation document (PDF 117 KB)

Published:

25 February 2014

Other information

CG30 Long-acting reversible contraception: guideline recommendations tool information

Background information

Scope: Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception (PDF 131 KB)

Published:

10 January 2003

Original development documents 2003 - 2005

Original development documents 2003 - 2005 information
Long-acting reversible contraception clinical guideline - second consultation information
Long-acting reversible contraception clinical guideline - second consultation, full guideline (PDF 1.6 MB)

Published:

23 May 2005
Long-acting reversible contraception clinical guideline - second consultation, NICE guideline (PDF 321 KB)

Published:

23 May 2005
Long-acting reversible contraception clinical guideline - second consultation, algorithm (PDF 129 KB)

Published:

23 May 2005
Long-acting reversible contraception clinical guideline - second consultation, information for the public (PDF 89 KB)

Published:

23 May 2005
Long-acting reversible contraception clinical guideline - second consultation, comments proforma (MSWord 42 KB)

Published:

23 May 2005
click here information
Long-acting reversible contraception clinical guideline - first consultation information
Long-acting reversible contraception clinical guideline - first consultation, full guideline (PDF 1.58 MB)

Published:

07 March 2005
Long-acting reversible contraception clinical guideline - first consultation, NICE guideline (PDF 87 KB)

Published:

07 March 2005
Long-acting reversible contraception clinical guideline - first consultation, algorithm (PDF 28 KB)

Published:

07 March 2005
Long-acting reversible contraception clinical guideline - first consultation, comments proforma (MSWord 43 KB)

Published:

07 March 2005
Long-acting contraception - list of stakeholders (PDF 23 KB)

Published:

21 December 2004
Scope: Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception (PDF 131 KB)

Published:

10 January 2003
Long-acting reversible contraception: Final Consultation Table (PDF 278 KB)

Published:

10 January 2003
Long-acting contraception Remit information
Members of the Guideline Development Group: Long-acting contraception (PDF 17 KB)

Published:

09 February 2004
Draft Scope: Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception information

Long acting reversible contraception (update): consultation comments table

Long acting reversible contraception (update): consultation comments table (PDF 358 KB)

Published:

03 September 2014

Long acting reversible contraception (update): equality impact assessment

Long acting reversible contraception (update): equality impact assessment (PDF 153 KB)

Published:

03 September 2014

Long Acting Reversible Contraception: addendum consultation

Long Acting Reversible Contraception: addendum consultation information
Long Acting Reversible Contraception: addendum consultation (PDF 3.34 MB)

Published:

11 June 2014
Long acting reversible contraception (update): stakeholder list (PDF 30 KB)

Published:

11 June 2014

Updates Standing Committee (CGU) meetings

Updates Standing Committee (CGU) meetings information

Long acting reversible contraception (update): Topic Expert Committee members list

Long acting reversible contraception (update): Topic Expert Committee members list (PDF 61 KB)

Published:

20 March 2014

Long acting reversible contraception (update): stakeholder list

Long acting reversible contraception (update): stakeholder list (PDF 30 KB)

Published:

11 June 2014

Long acting reversible contraception (update): Final scope

Long acting reversible contraception (update): Final scope
Long acting reversible contraception (update): scope (PDF 167 KB)

Published:

19 February 2014
LARC Topic Expert Members List (PDF 59 KB)

Published:

27 February 2014

Long acting reversible contraception (update): Standing Committee A members

Long acting reversible contraception (update): Standing Committee A members (PDF 144 KB)

Published:

19 February 2014